Form EFFECT Addex Therapeutics Ltd.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 5, 2025 4:15 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Diabetic Retinopathy Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
- Search2light Solutions Embeds with Grimes Carbon Technologies to Accelerate Commercialization
- CALIFORNIA SCIENCE CENTER UNVEILS SAMUEL OSCHIN AIR AND SPACE CENTER WITH 100 INTERACTIVE EXHIBITS AND RARE ARTIFACTS
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share